TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 19.10
-0.40 (-2.05%)
Sep 8, 2026, 12:05 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 667.34 million as of September 8, 2026. Its market cap has decreased by -24.36% in one year.
Market Cap
667.34M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.10
ChartMarket Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 667.34M, a decrease of -71.59%. That is a compound annual growth rate of -31.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 667.34M | -10.75% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.91B |
| Puriblood Medical | 1.07B |
| Genetics Generation Advancement | 1.05B |
| Kim Forest Enterprise | 745.74M |
| Sofiva Genomics | 736.33M |
| Welgene Biotech | 379.86M |
| Pharmigene | 368.90M |